1221 Tech Court,
About Us
WES Pharma Inc is a dynamic and emerging specialty pharmaceutical company focused on developing and manufacturing difficult to develop, technology-driven specialty generics for the US markets. WES nurtures the entire product lifecycle-from the early stages of R&D through U.S. Food and Drug Administration (FDA) approval and manufacturing the approved product. WES’s professional team of scientists has expertise in developing multitude of dosage forms. WES develops majority of its products in-house in addition to partnering with other pharmaceutical companies to synergize development, manufacturing, and marketing capabilities.
WES’s business model is to develop complex generic and innovative specialty pharmaceutical products in oral solids and liquids forms.
WES’s program is targeted on developing those generic drug products that are:
• Difficult to develop for technical and scientific reasons
• No or very limited Active Pharmaceutical Ingredient (API) source
• Niche area of use
• Complicated manufacturing
• Complicated bio-equivalency or clinical studies
• Potential to provide value to patients and prescribers, in terms of cost effectiveness
WES has a broad portfolio of products under development, with formulations including tablets, capsules, solutions and suspension. WES's pipeline includes molecules with solubility and stability challenges, as well as difficult to produce and characterize polypeptides and carbohydrates. WES has a comprehensive infrastructure for the development of its products in its state of the art R&D facility in Westminster, MD.
R&D infrastructure:
WES’s scope of R&D activities include analytical characterization, method development and validation, pre-formulation, formulation and manufacturing process development and optimization, as well as stability testing under ICH and current Good Manufacturing Practices (cGMP) guidelines.
WES’s product development efforts are supported by complementary functional areas, including Project Management, Quality Assurance, Regulatory Operations & Affairs, Data Management, Pre-clinical and Clinical expertise, Commercial Supply Operations, as well as a comprehensive administrative, HR and IT infrastructure.
Management:
WES’s scope of R&D activities include analytical characterization, method development and validation, pre-formulation, formulation and manufacturing process development and optimization, as well as stability testing under ICH and current Good Manufacturing Practices (cGMP) guidelines.
Our management team comprises of professionals who have wide array of experience in management, marketing, development, research and manufacturing aspects of the pharmaceutical industry.